预防活体供肝移植中的小肝综合征:ILTS-iLDLT-LTSI 共识会议指南
小肝综合征是肝移植后公认并发症,活体供肝移植后发生率高达20%。国际肝移植学会、国际活体供肝移植组及印度肝移植学会于2023年1月召开共识会议,采用GRADE系统制定推荐。会议设4个工作组(诊断、预防、麻醉与重症监护、已确立小肝综合征的管理),工作组基于现有文献准备循证推荐,经独立专家组和参会者编辑确认。本报告呈现第2工作组关于预防活体供肝移植小肝综合征的最终声明和循证推荐。
要点
- 活体供肝移植后小肝综合征发生率高达20%,预防需贯穿术前供受体选择和术中操作。
- 术前因素包括供体和受体选择,术中因素包括充分的流出道重建、移植肝门静脉流入调节和门体分流管理。
- 共识会议于2023年1月召开,采用GRADE系统制定推荐,第2工作组负责预防部分。
- 推荐基于现有文献的循证证据,经独立专家组和参会者编辑确认。
适用人群与场景
- 接受活体供肝移植的患者
处置流程与药物剂量
- 预防小肝综合征需考虑术前因素(供体和受体选择)及术中因素(充分的流出道重建、移植肝门静脉流入调节、门体分流管理)。
研究设计与关键结果
- 国际肝移植学会、国际活体供肝移植组和印度肝移植学会共识会议于2023年1月召开,采用GRADE系统,设4个工作组(诊断、预防、麻醉与重症监护、已确立小肝综合征的管理),工作组基于现有文献准备循证推荐,经独立专家组和参会者编辑确认,本报告呈现第2工作组关于预防活体供肝移植小肝综合征的最终声明和循证推荐。
证据类型、等级与局限
- 证据类型:指南/共识;采用GRADE系统制定推荐;局限:原文未报告局限性
对床旁实践的改变
- 作者认为,预防活体供肝移植后小肝综合征需在术前考虑供体和受体选择,术中注意充分的流出道重建、移植肝门静脉流入调节和门体分流管理。
指南或共识出处
- 指南名称:Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference;发布机构:国际肝移植学会(ILTS)、国际活体供肝移植组(iLDLT)、印度肝移植学会(LTSI);年份:2023年
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Small-for-size syndrome (SFSS) is a well-recognized complication following liver transplantation (LT), with up to 20% developing this following living donor LT (LDLT). Preventing SFSS involves consideration of factors before the surgical procedure, including donor and recipient selection, and factors during the surgical procedure, including adequate outflow reconstruction, graft portal inflow modulation, and management of portosystemic shunts. International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplant Society of India Consensus Conference was convened in January 2023 to develop recommendations for the prediction and management of SFSS in LDLT. The format of the conference was based on the Grading of Recommendations, Assessment, Development, and Evaluation system. International experts in this field were allocated to 4 working groups (diagnosis, prevention, anesthesia, and critical care considerations, and management of established SFSS). The working groups prepared evidence-based recommendations to answer-specific questions considering the currently available literature. The working group members, independent panel, and conference attendees served as jury to edit and confirm the final recommendations presented at the end of the conference by each working group separately. This report presents the final statements and evidence-based recommendations provided by working group 2 that can be implemented to prevent SFSS in LDLT patients.
参考来源
- Hakeem AR, Mathew JS, Aunés CV, et al. Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference. Transplantation. 2023. PMID: 37635285. doi:10.1097/TP.0000000000004769
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。